Ozempic works by mimicking a gut hormone called GLP-1 that your body naturally produces after eating. The drug’s active ingredient, semaglutide, activates GLP-1 receptors throughout your body, triggering a chain of effects that reduce hunger, slow digestion, and shift how your brain responds to food. In the landmark STEP 1 clinical trial, participants lost an average of 14.9% of their body weight over 68 weeks, compared to just 2.4% in the placebo group.
It Slows Your Digestion Significantly
One of the most immediate ways semaglutide causes weight loss is by slowing down how fast food leaves your stomach. Normally, your stomach empties within a few hours after a meal. Semaglutide delays that process substantially. A pooled analysis of studies found that GLP-1 drugs increased gastric transit time by an average of about 45 minutes. People taking semaglutide are also nearly five times more likely to have food still sitting in their stomach longer than expected compared to people not on the drug.
This slower emptying means food sits in your stomach longer, which keeps stretch receptors activated and satiety signals firing. The practical result: you feel full faster during meals and stay full longer afterward. Many people on Ozempic report being unable to finish portions they previously ate with ease. This naturally reduces how many calories you consume without requiring willpower or calorie counting, though both still help.
It Changes How Your Brain Responds to Food
Semaglutide doesn’t just work in your gut. GLP-1 receptors exist in several brain regions that control appetite and reward, and the drug crosses into the brain to act on them directly. This is what many people describe as the quieting of “food noise,” that constant background hum of thinking about what to eat next.
Research on how semaglutide affects the brain’s reward system has revealed something interesting. In animal studies, the drug increased activity in dopamine-producing neurons during actual food consumption but not during the anticipatory cue before food arrived. In plain terms, semaglutide appears to dampen the craving and anticipation side of eating while preserving (or even enhancing) the satisfaction you get from food once you’re actually eating it. This may explain why many users report fewer obsessive food thoughts and less interest in snacking, without feeling like food has become joyless.
The appetite-suppressing effects also work through the hypothalamus, the brain region that regulates hunger and energy balance. By activating GLP-1 receptors there, semaglutide turns down the biological drive to eat in a way that feels automatic to most people rather than like constant resistance.
It Improves How Your Body Handles Blood Sugar
Ozempic was originally developed for type 2 diabetes, and its metabolic effects contribute to weight loss too. Semaglutide enhances insulin release, but only when blood sugar is actually elevated. This glucose-dependent mechanism means it helps your body process sugar from meals more efficiently without pushing blood sugar dangerously low.
At the same time, semaglutide suppresses glucagon, a hormone that tells your liver to release stored sugar into the bloodstream. By dialing down glucagon when it’s not needed, the drug helps keep blood sugar more stable. Stable blood sugar means fewer energy crashes and fewer of those intense hunger spikes that drive overeating. Semaglutide has also been shown to increase energy expenditure and promote fat burning, which contributes to improvements in body composition beyond what calorie reduction alone would produce.
What You Actually Lose: Fat vs. Muscle
Not all weight loss is the same, and this is one area where Ozempic has drawn legitimate concern. When you lose weight on GLP-1 drugs, lean body mass (which includes muscle) can account for 15 to 40% of the total weight lost. With semaglutide specifically, research suggests roughly 28% of weight lost comes from lean mass rather than fat, meaning about 72% of the loss is fat.
That ratio matters because losing too much muscle can lower your metabolic rate, reduce strength, and create problems as you age. Resistance training and adequate protein intake during treatment can help shift the balance toward preserving muscle. Newer combination therapies are being studied that push fat loss above 90% of total weight lost, but for now, exercise remains the most accessible way to protect your muscle while on the drug.
How the Dose Ramps Up
Ozempic is a once-weekly injection that starts at a low dose and gradually increases. You begin at 0.25 mg per week for the first four weeks, which is primarily to let your body adjust and minimize side effects like nausea. At week five, the dose increases to 0.5 mg. From there, your prescriber may increase it further based on your response, up to a maximum of 2 mg per week. The gradual titration is why many people don’t notice dramatic appetite changes in the first month. The full effects typically build as the dose increases.
What Happens When You Stop
The weight loss from Ozempic depends on continuing the drug. A systematic review published in The Lancet found that at one year after stopping GLP-1 treatment, people had regained 60% of the weight they lost. This isn’t a failure of the drug so much as a reflection of what it’s doing: suppressing biological hunger signals and slowing digestion. When you remove that suppression, the underlying drivers of weight gain return.
This is why semaglutide is increasingly understood as a long-term medication rather than a short course. The same way blood pressure medication controls hypertension only while you take it, Ozempic manages appetite and metabolic signals only while it’s active in your system. People who build sustainable habits around diet and exercise during treatment tend to regain less, but biology is a powerful force, and most people will see significant rebound without ongoing treatment or a clear maintenance strategy.